GB Patent

GB0513058D0 — Organic compounds

Assigned to Sandoz AG · Expires 2005-08-03 · 21y expired

What this patent protects

A pleuromutilin in the form of a salt with salicylic acid, azelaic acid, sebacic acid or 2-[(2,6-dichlorophenyl)amino]benzeneacetic acid.

USPTO Abstract

A pleuromutilin in the form of a salt with salicylic acid, azelaic acid, sebacic acid or 2-[(2,6-dichlorophenyl)amino]benzeneacetic acid.

Drugs covered by this patent

Altabax (RETAPAMULIN) · Almirall

Patent Metadata

Patent number: GB0513058D0
Jurisdiction: GB
Classification: —
Expires: 2005-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Sandoz AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.